Disease activity and blood tests at canakinumab introduction and during follow-up
| Daily prednisone dose mg | Baseline (n=13) | 3 months (n=13) | 6 months (n=11) | 12 months (n=5) | 18 months (n=2) |
|---|---|---|---|---|---|
| Pouchot score | 15 (5-80) | 7.5 (2.5-12.5) | 5 (0-7.5) | 5 (0-7.5) | 2.5 |
| VAS pain | 3 (2-5) | 1 (0-2) | 0 (0-1) | 0 | 0 |
| Erythrocyte sedimentation rate mm/h | 7 (2-10) | 3 (1-8) | 2 (1-4) | 1 (1-2) | 1 |
| C-reactive protein mg/L | 42 (8-120) | 21 (2-69) | 13 (2-55) | 14 (2-41) | 11 |
| Ferritin ng/mL | 20.8 (3-180) | 3.1 (0.5-22.5) | 1.6 (0.5-8.4) | 1 (0.3-6.3) | 0.5 |
| Hemoglobin g/dL | 379.5 (161-914) | 282 (82-552) | 215 (34-464) | 177 (77-401) | 199 |
| 13.1 (9.4-15.7) | 13.2 (10.7-15.3) | 13.8 (11.5-15.5) | 13.9 (11.3-14.3) | 13.5 |